Cargando…
Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity
Doxorubicin is the mainstay of treatment for various haematological malignancies and solid tumours. However, its clinical application may be hampered by dose-dependent cardiotoxicity. The mechanism of doxorubicin-induced cardiotoxicity may involve various signalling pathways including free radical g...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594674/ https://www.ncbi.nlm.nih.gov/pubmed/26177159 http://dx.doi.org/10.1111/jcmm.12633 |